Instil Bio (TIL) Other Non-Current Liabilities (2020 - 2026)

Instil Bio has reported Other Non-Current Liabilities for 7 years, with the latest figure at $8000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 99.16% year-over-year to $8000.0 in Q1 2026; TTM through Mar 2026 was $8000.0, a 99.16% decrease from a year earlier, with the FY2025 full-year figure at $8000.0, down 99.16% from the prior year.
• Other Non-Current Liabilities was $8000.0 for Q1 2026 at Instil Bio, roughly flat from $8000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $11.1 million in Q1 2022, with the low at $8000.0 in Q4 2025.
• Average Other Non-Current Liabilities over 5 years is $5.0 million, with a median of $5.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities advanced 2.66% in 2022, then sank 99.16% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $7.9 million in 2022, then tumbled by 38.37% to $4.9 million in 2023, then tumbled by 80.49% to $948000.0 in 2024, then tumbled by 99.16% to $8000.0 in 2025, then changed by 0.0% to $8000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $8000.0 (Q1 2026), $8000.0 (Q4 2025), and $948000.0 (Q3 2025), per Business Quant data.